by Maria Zannes | Aug 25, 2016 | Articles, News
AUGUST 25, 2016 As published in the San Antonio Business Journal By W. Scott Bailey City Council authorized the San Antonio Economic Development Corporation on Thursday to directly invest in bioAffinity Technologies. It’s another indication that City Hall is...
by Maria Zannes | Jul 13, 2016 | News
JULY 13, 2016 As published in the San Antonio Business Journal By W. Scott Bailey One of San Antonio’s more promising bioscience companies, bioAffinity Technologies Inc., has locked up a key deal, renewing its collaborative agreement with the University of Texas...
by Maria Zannes | Jul 8, 2016 | News
JULY 8, 2016 As published in the San Antonio Business Journal By W. Scott Bailey San Antonio’s bioAffinity Technologies Inc. has hired a senior executive with strong ties to the city’s bioscience industry to help lead its new subsidiary — OncoSelect...
by Maria Zannes | Apr 9, 2016 | News
APRIL 9, 2016 As published in the San Antonio Business Journal By W. Scott Bailey San Antonio based bioAffinity Technologies is moving closer to commercializing its initial cancer diagnostics technology via a combination of new funding and strategic hires, according...
by Maria Zannes | Apr 6, 2016 | News
APRIL 6, 2016 As published in the San Antonio Express News By Peggy O’Hare, Staff Writer The problem with early lung cancer screening is the unnecessary worry for the 97 percent of patients flagged with suspicious results — that ultimately turn out to be inaccurate....
by Maria Zannes | Dec 16, 2015 | News
DECEMBER 16, 2015 As published in the San Antonio Business Journal By W. Scott Bailey The People’s Republic of China has awarded a Certificate of Invention Patent to bioAffinity Technologies for its proprietary CyPath® assay, which could have a profound impact on...
